These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 25631678

  • 1. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
    Chen SL, Zhang JJ, Ye F, Tian NL, Sheiban I, Jepson N, Paiboon C, Sansoto T, Kwan TW, Wen SY, Wang HC, Jiang TM, Wang Y, Chen LL, Qiu CG, Zhang YJ, Chen MX, De Maria A.
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
    [Abstract] [Full Text] [Related]

  • 2. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [Abstract] [Full Text] [Related]

  • 3. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 4. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).
    Cockburn J, Behan M, de Belder A, Clayton T, Stables R, Oldroyd K, Curzen N, Hildick-Smith D.
    Heart; 2012 Oct 01; 98(19):1431-5. PubMed ID: 22851684
    [Abstract] [Full Text] [Related]

  • 5. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.
    Tandjung K, Basalus MW, Muurman E, Louwerenburg HW, van Houwelingen KG, Stoel MG, de Man FH, Jansen H, Huisman J, Linssen GC, Droste HT, Nienhuis MB, von Birgelen C.
    Catheter Cardiovasc Interv; 2012 Oct 01; 80(4):524-30. PubMed ID: 22109857
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators.
    JACC Cardiovasc Interv; 2009 Nov 01; 2(11):1074-82. PubMed ID: 19926047
    [Abstract] [Full Text] [Related]

  • 7. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
    Kawamoto H, Panoulas VF, Sato K, Miyazaki T, Naganuma T, Sticchi A, Figini F, Latib A, Chieffo A, Carlino M, Montorfano M, Colombo A.
    JACC Cardiovasc Interv; 2015 Jun 01; 8(7):900-9. PubMed ID: 26003020
    [Abstract] [Full Text] [Related]

  • 8. Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.
    Lee SW, Lee PH, Kang SH, Choi H, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ.
    JACC Cardiovasc Interv; 2016 Nov 14; 9(21):2220-2228. PubMed ID: 27832848
    [Abstract] [Full Text] [Related]

  • 9. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW.
    JACC Cardiovasc Interv; 2015 Jul 14; 8(8):1053-1063. PubMed ID: 26205444
    [Abstract] [Full Text] [Related]

  • 10. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
    Chen SL, Sheiban I, Xu B, Jepson N, Paiboon C, Zhang JJ, Ye F, Sansoto T, Kwan TW, Lee M, Han YL, Lv SZ, Wen SY, Zhang Q, Wang HC, Jiang TM, Wang Y, Chen LL, Tian NL, Cao F, Qiu CG, Zhang YJ, Leon MB.
    JACC Cardiovasc Interv; 2014 Nov 14; 7(11):1266-76. PubMed ID: 25326748
    [Abstract] [Full Text] [Related]

  • 11. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 14; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K, j-Cypher Registry Investigators.
    JACC Cardiovasc Interv; 2013 Jul 14; 6(7):654-63. PubMed ID: 23866178
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW.
    JACC Cardiovasc Interv; 2013 Sep 14; 6(9):914-22. PubMed ID: 24050859
    [Abstract] [Full Text] [Related]

  • 14. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Zhang Q, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Kirtane AJ, Zhang RY.
    Catheter Cardiovasc Interv; 2016 Mar 14; 87 Suppl 1():616-23. PubMed ID: 26864270
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun 14; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 16. Periprocedural myocardial infarction is not associated with an increased risk of long-term cardiac mortality after coronary bifurcation stenting.
    Song PS, Song YB, Yang JH, Kang GH, Hahn JY, Choi SH, Choi JH, Lee SH, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ, Gwon HC.
    Int J Cardiol; 2013 Aug 20; 167(4):1251-6. PubMed ID: 22494861
    [Abstract] [Full Text] [Related]

  • 17. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.
    JACC Cardiovasc Interv; 2013 Dec 20; 6(12):1233-41. PubMed ID: 24239199
    [Abstract] [Full Text] [Related]

  • 18. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW.
    Heart; 2012 Oct 20; 98(19):1424-30. PubMed ID: 22821273
    [Abstract] [Full Text] [Related]

  • 19. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Kim JH, Kim BK, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Catheter Cardiovasc Interv; 2018 Sep 01; 92(3):477-485. PubMed ID: 29266736
    [Abstract] [Full Text] [Related]

  • 20. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.
    Ozcan OU, Ustun EE, Gulec S, Gerede DM, Goksuluk H, Vurgun VK, Kaya CT, Erol C.
    Cardiol J; 2015 Sep 01; 22(3):323-9. PubMed ID: 25563711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.